VA Launches Psychedelic Drug Trial for Veterans: Here's Who Can Take Part
Summary
The Department of Veterans Affairs (VA) started a new medical trial to test psilocybin, a psychedelic drug, for treating depression in veterans who have not improved with other treatments. This effort follows an executive order from President Donald Trump to expand psychedelic drug trials to help people with serious mental health problems.Key Facts
- The VA's new trial is called the Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression.
- It includes veterans with major depressive disorder that does not respond to typical treatments, including some with PTSD.
- Participants will receive two different doses of psilocybin, the active ingredient in magic mushrooms, to compare effects.
- The trial is taking place at five VA medical centers across the U.S., including sites in Alabama, Oregon, Pennsylvania, and Washington.
- The VA warns veterans not to self-medicate with psychedelics and to consult their doctors before changing treatments.
- This study is part of a larger effort: the VA is running 20 trials on psychedelic treatments for mental health conditions.
- The Food and Drug Administration (FDA) has given special status to some drugs like MDMA, LSD, and psilocybin to speed up research.
- The VA and Department of Health and Human Services have agreed to work together to support these trials and provide training to medical staff.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
